One of the principal tools of personalized medicine is the use of companion diagnostics. In this first article in a two-part series on the opportunities and challenges that confront the rise of companion diagnostics, we use case studies to review the different roles that these products and services could play in the continued growth of the pharmaceutical industry. The article can be found here:
Supply chain management in the AI era: A vision statement from the operations management community
CRA’s Maxime Cohen is a contributor to the academic and industry leader team releasing the vision statement “Supply Chain Management in the AI era: A Vision...